Rheumatology Research Foundation

Home
United States
Atlanta, GA
Rheumatology Research Foundation

The largest private funding source for rheumatology research & training in the U.S.

The Foundation is the largest private funding source of rheumatology research and training in the United States. Since 1985, the Foundation has committed more than $181 million directly to research and training and granted 3,734 individual awards. The Foundation has received a four-star rating, the highest offered by Charity Navigator, for 12 years in a row because of its good governance, sound fiscal management and commitment to accountability and transparency.

06/04/2026

Rare diseases like DADA2 can cause life-threatening inflammation, strokes, bone marrow failure, and other serious complications — but researchers are working to better understand why patients experience the disease so differently.

With support from the Rheumatology Research Foundation’s Career Development Bridge Funding: R Bridge award, Dr. Lee’s research is uncovering key immune system pathways involved in DADA2 and helping pave the way for more personalized treatments in the future.

Findings from his research may impact patients by:

✨Helping doctors better predict how DADA2 will affect each patient, allowing earlier diagnosis, closer monitoring, and more personalized care.

✨ Leading to more targeted treatments by identifying the specific immune pathways involved in different forms of the disease.

✨ Building resources for future discoveries, including patient biobanks and laboratory models that may accelerate the development of new therapies for DADA2 and related inflammatory diseases.

Learn more about this research and its impact on the RheumLab. https://rheumlab.org/understanding-inflammation-in-a-rare-disease-called-dada2/

06/02/2026

The Foundation is accepting applications for the Scientist Development Award. Investigators in the early stages of their career or who do not have significant prior research experience are welcome to apply for funding to conduct innovative research.

Required letters of intent are due July 1, 2026 by 5 PM ET and applications are due by August 3, 2026 by 5 PM ET. https://www.rheumresearch.org/career-development-research-awards

05/28/2026

With Corporate Roundtable sponsors like Takeda, the Foundation can continue funding programs that train the next generation of rheumatology professionals, support young investigators as they pursue promising research ideas, and advance cutting-edge research projects.

Takeda’s unwavering commitment to putting patients first and addressing unmet medical needs has led to meaningful scientific discoveries and the development of life-transforming treatments across their core therapeutics areas.

05/21/2026

With support from the Foundation’s Scientist Development Award, Dr. Tarin Bigley investigated how neonatal infections might disrupt immune tolerance and lead to the development of autoimmune diseases, like lupus, later in life.

Findings from this project could impact the lives of patients by:

✨Helping doctors identify people at risk for lupus earlier, before symptoms appear.

✨ Leading to new ways to prevent or delay lupus by understanding how childhood viral infections affect the immune system.

✨ Supporting the development of more personalized lupus treatments by improving understanding of how environmental exposures shape immune system dysfunction over time.

These findings move the field closer to understanding why lupus develops — not just how to treat it after diagnosis.

Learn more about Dr. Bigley's project in the Foundation’s 2025 Annual Report. https://bit.ly/4dyoPxJ

05/20/2026

At the Rheumatology Research Foundation, our mission is clear: to advance research and training to improve the health of patients living with rheumatic disease.

To accomplish this, we focus on two critical mission priorities:

🥼 Workforce Expansion
The demand for rheumatology care continues to grow. We are committed to recruiting and training the next generation of rheumatology professionals to ensure patients have access to the high-quality care they deserve.

🔬 Accelerating Discoveries
Through strategic funding of innovative scientific research, we are driving breakthroughs that expand treatment options and move us closer to a future cure.

Together, these priorities strengthen the field of rheumatology and bring hope to millions of patients and families.

Learn more about how we’re building the future of rheumatology and how you can be part of it at RheumResearch.org

05/19/2026

I’ve seen how far rheumatology has come and how much potential still lies ahead.

That’s why I’m supporting the Rheumatology Research Foundation through planned giving. It’s my way of strengthening the pipeline of researchers and healthcare professionals and accelerating the discoveries that will shape patient care for generations.

And so can you when you become a member of the Foundation’s Legacy Society. This is our field—and its future depends on all of us. Join us today!

https://legacy.rheumresearch.org/contact-us

05/15/2026

If you are revising an outstanding NIH R01 or VA RCS/ORD award application and are at risk of running out of research funding, you may be eligible for the Career Development Bridge Funding Award: R Bridge!

This award helps to sustain promising research careers during critical funding gaps.

Applications are due June 1, 2026 by 5 PM ET. https://bit.ly/3P2nqri

05/14/2026

The Rheumatology Research Foundation is led by volunteers in the rheumatology community who are passionate about creating brighter futures for people living with rheumatic disease. Get involved with the Foundation by joining a council, peer review study section or the board of directors today! Applications are due June 1, 2026. https://rheumatology.org/volunteering

05/12/2026

Despite advances in the field, many people still have limited treatment options for inflammatory diseases. Gilead Sciences is leveraging its extensive expertise in immunology to unlock next-generation therapies with the hope of bringing effective treatments to as many people as possible.

Through the Corporate Roundtable, Gilead continues to be a strong supporter of the Foundation as it fulfills its mission to advance scientific breakthroughs, strengthen the rheumatology workforce, and improve the lives of people living with rheumatic disease.

05/10/2026

Today is , a day dedicated to raising awareness about lupus, a serious and potentially life threatening autoimmune disease affecting millions worldwide. While progress in research and treatment is ongoing, continued efforts are crucial to advance care and ultimately find a cure.

You can help this Lupus Awareness Month by:
• Wearing purple 💜 today (and throughout May)
• Sharing trustworthy information with friends and family
• Supporting people living with lupus by listening, learning, and showing up

Want to dig deeper? Learn more about new ways the Foundation is supporting accelerated discoveries and early career investigators working on next generation lupus diagnostics and treatments. https://bit.ly/4m7e4X1

Address

Atlanta, GA

Telephone

+14043651373

Website

http://rheumresearch.org/

Alerts

Be the first to know and let us send you an email when Rheumatology Research Foundation posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

The Maale Foundation
Rock City, Juba

Want your organization to be the top-listed Non Profit Organization in Atlanta?